drugset / Trial / NCT07086313
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in pediatric ADHD patients.
Timeline
- Start
- 2025-09-03
- Primary completion
- 2027-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Centanafadine | Small molecule | — | Oral |